Archive: Oracle Health

Premium
Andy Gordon first recommended Oracle Health to First Stage Investor members in February. The company is developing a long-term insertable cardiac monitor for heart failure.  Oracle has ambitious — but achievable — plans to get FDA clearance by the middle of next year. And the company has made exciting progress since Andy first recommended it. In today’s Startup Insider, Andy and Vin Narayanan catch up…
Premium

New Pick: Invest in Detecting Heart Failure Early

By Andy Gordon on February 25, 2021

Deal Details Startup: Oracle Health Security type: Stock Purchase Agreement Price per security: $2.00 Valuation: $20 million Minimum investment: $250 Where to invest: Republic Deadline…